semaglutide pharmaceutical company Novo Nordisk faces off in court with South African weight-loss drug compounder South Africa regulator reviews 12

But what we found out and what we realized was that this was really a part of the precursor of the hormone glucagon

Rapid and significant weight loss can cause: The rapid facial ageing associated with glucagon-like peptide-1 (GLP-1) medications is thought to be caused by several factors, including the loss of skin white adipose tissue (fat), changes in stem cell development, and hormonal and metabolic factors

During a video consultation, your MDWatch provider reviews your medical history, current medications, and goals to determine whether GLP1 is appropriate

doi: 10.1038/s42255-019-0041-z

Many online programs offer virtual consultations and home delivery, making it easy to stay consistent